Evidence map›Paper›PMID 28963573›Full record

ArticleNeuroradiology2018

Added value of multiphase CTA imaging for thrombus perviousness assessment.

E M M Santos, C D d'Esterre, K M Treurniet, W J Niessen, M Najm, M Goyal, A M Demchuk, C B Majoie, B K Menon, H A Marquering and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Neuroradiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 29 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Observational
  17. Article
  18. Clot Pathophysiology: Why Is It Clinically Important?Neuroimaging clinics of North America · 2018
    Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

E M M SantosDepartment of Biomedical Engineering and Physics, Academic Medical Center, Amsterdam, The Netherlands.
C D d'EsterreDepartments of Neurosciences, Radiology and Community Health Sciences, University of Calgary, Calgary, Canada.
K M TreurnietDepartment of Radiology and Nuclear Medicine, Academic Medical Center, Amsterdam, The Netherlands.
W J NiessenDepartment of Medical Informatics, Erasmus Medical Center, Rotterdam, The Netherlands.
M NajmDepartments of Neurosciences, Radiology and Community Health Sciences, University of Calgary, Calgary, Canada.
M GoyalDepartments of Neurosciences, Radiology and Community Health Sciences, University of Calgary, Calgary, Canada.
A M DemchukDepartments of Neurosciences, Radiology and Community Health Sciences, University of Calgary, Calgary, Canada.
C B MajoieDepartment of Radiology and Nuclear Medicine, Academic Medical Center, Amsterdam, The Netherlands.
B K MenonDepartments of Neurosciences, Radiology and Community Health Sciences, University of Calgary, Calgary, Canada.
H A MarqueringDepartment of Biomedical Engineering and Physics, Academic Medical Center, Amsterdam, The Netherlands. h.a.marquering@amc.uva.nl.ORCID http://orcid.org/0000-0002-1414-6313
PRove-IT investigators
University of Calgary · CAAmsterdam UMC Location University of Amsterdam · NLErasmus MC · NL

Funding

ITEA3 10004Stichting voor de Technische Wetenschappen 11632
6 · The paper itself

Abstract

purposeThrombus perviousness has been associated with favorable functional outcome in acute ischemic stroke (AIS) patients. Measuring thrombus perviousness on CTA may be suboptimal due to potential delay in contrast agent arrival in occluded arteries at the moment of imaging. Dynamic sequences acquired over time can potentially overcome this issue. We investigate if dynamic CTA has added value in assessing thrombus perviousness.

methodsProspectively collected image data of AIS patients with proven occlusion of the anterior or posterior circulation with thin-slice multi-phase CTA (MCTA) and non-contrast CT were co-registered (n = 221). Thrombus attenuation increase (TAI; a perviousness measure) was measured for the arterial, venous, and delayed phase of the MCTA and time-invariant CTAs (TiCTA). Associations with favorable clinical outcome (90-day mRS ≤ 2) were assessed using univariate and multivariable regressions and calculating areas under receiver operating curves (AUC).

resultsTAI determined from the arterial phase CTA was superior in the association with favorable outcome with OR = 1.21 per 10 HU increase (95%CI 1.04-1.41, AUC 0.62, p = 0.014) compared to any other phase (venous 1.14(95%CI 1.01-1.30, AUC 0.58, p = 0.033), delayed 1.046(95%CI 0.919-1.19, AUC 0.53, p = 0.50)), and TiCTA (1.15(95%CI 1.02-1.30, AUC 0.60, p = 0.022). In the multivariable model, only TAI on arterial phase was significantly associated with favorable outcome (aOR 1.59, 95%CI 1.04-2.43, p = 0.032).

conclusionAssociation between TAI with functional outcome was optimal on arterial-phase CTA such that dynamic CTA imaging has no additional benefits in current thrombus perviousness assessment, thereby suggesting that the delay of contrast arrival at the clot is a key variable for patient functional outcome.

Indexed as

AgedAged, 80 and overBrain IschemiaCerebral AngiographyComputed Tomography AngiographyContrast MediaFemaleHumansIntracranial ThrombosisMaleMiddle AgedRetrospective StudiesTriiodobenzoic AcidsContrast MediaioversolTriiodobenzoic AcidsAcute ischemic strokeCTACT multi-phaseThrombus characteristicsThrombus permeability

Identifiers

PMID28963573
PMCPMC5748434
OpenAlexW2760714555

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.